The $22 Billion Bet on 3D Printed Hip and Knee Implants

When Your New Knee Is Built by a Printer

Every ninety seconds or so, a surgeon in the United States replaces someone's knee. That's over 790,000 total knee replacements performed annually in this country alone, according to the American Academy of Orthopaedic Surgeons. Add more than 450,000 hip replacements to that figure, and you're looking at a sector of medicine that has operated, for decades, with an almost industrial logic — stock a warehouse with standard-sized components, match the closest size to the patient, and hope the fit is good enough. The premise is being quietly dismantled. The 3D printed hip and knee implants market is valued at roughly $4.1 billion in 2025 and is projected to reach $22.2 billion by 2035 — a growth rate of 18.4% annually. A detailed breakdown of this trajectory is available in this 3D printed orthopedic implants industry overview. The numbers are striking, but the more interesting story is why.

The Off-the-Shelf Problem Nobody Talks About

Standard implants come in sizes. S, M, L — or the numerical equivalent. An orthopedic surgeon working on a patient with unusual bone geometry, prior trauma, or severe joint deformity has always had to improvise around whatever inventory the hospital stocks. The results are serviceable often enough that the system persisted for half a century. But "serviceable" and "optimal" are not the same thing, and the gap between them shows up years later in revision surgeries, chronic discomfort, or implants that simply loosen sooner than they should.

Additive manufacturing changes the equation. A CT scan of the patient's joint goes into planning software. The software generates a model. The printer — typically working in titanium or cobalt-chromium powder — builds an implant with lattice structures calibrated to that specific person's anatomy. The porous surface mimics the architecture of natural bone, encouraging the patient's own tissue to grow directly into the implant rather than relying on cement for fixation. Cementless fixation now accounts for 45.6% of the market, and that share is climbing, precisely because surgeons have seen what happens when bone and implant become genuinely integrated rather than merely attached.

What the Numbers Inside the Numbers Actually Say

Stryker, headquartered in Michigan, is probably the most instructive case study here. The company has manufactured millions of implants using additive manufacturing since the early 2010s through its proprietary Tritanium porous platform. Its knee implant revenue grew from $2,273 million in 2023 to $2,656 million in 2025 — an increase of about 17% across two years. That's not hype. That's hospitals ordering at scale.

The hip side of the market tells a more complicated story. Zimmer Biomet, one of Stryker's main competitors, saw hip segment revenue inch from $1,967 million in 2023 to $1,999 million in 2024 — growth of barely 1.6%. The hesitancy reflects something real: many surgeons were trained on traditional acetabular cup systems, know them intimately, and see limited short-term incentive to retrain for a newer workflow. Disruption in medicine tends to move through a generational filter.

Metallic implants still dominate the material breakdown, holding a 71.3% share of the market. That's unlikely to shift dramatically in the near term. Titanium works. It integrates well, handles load, and tolerates the mechanical demands of a joint that may cycle through a million compression events per year. The innovation isn't replacing the material so much as reshaping what you can do with it — the lattice geometries and patient-specific contours that traditional machining simply cannot produce.

Regulatory Milestones Are Moving Faster Than Expected

For a long time, the regulatory picture was a genuine drag on adoption. Custom implants require individualized review, and the FDA's frameworks weren't originally designed for devices that might be unique in every production run. That's changing. In March 2025, restor3d received 510(k) clearance for its iTotal Identity Cruciate Retaining 3DP Porous Knee Replacement System — a cementless, fully additively manufactured primary knee implant. The same month, Maxx Orthopedics cleared its 3D printed porous titanium tibial baseplate for the Freedom Total Knee System. China's National Medical Products Administration granted clearance for a laser-based 3D printed total knee replacement developed by Naton Biotechnology, marking the first such approval in the country's history.

Taken together, these approvals in a single quarter represent a pace of regulatory progress that would have seemed optimistic two or three years ago. Each cleared device also functions as a template, demonstrating to regulators that consistent porosity gradients and reproducible lattice structures can be validated at scale. The 3D printed hip and knee implants market is benefiting from this accumulated proof of concept in ways that will compound through the remainder of the decade.

Where Growth Is Actually Coming From

North America holds 43.8% of the current market, which makes sense given the procedural volume and the concentration of device manufacturers. The more striking growth story, though, is Asia Pacific, which is expected to post the highest compound annual growth rate through 2035. Population aging in China, Japan, and South Korea is generating an orthopedic caseload that existing implant supply chains weren't built to handle. Domestic manufacturing ambitions — including China's regulatory push with Naton Biotechnology — suggest the region won't simply import solutions from Michigan or Warsaw, Indiana. It's building capacity.

The macroeconomic headwinds are real and worth acknowledging. Titanium powder costs are sensitive to inflation. US tariffs on imported additive manufacturing hardware raise equipment costs for suppliers. Smaller orthopedic centers may defer adoption simply because the capital outlay for a printing workflow is higher than expanding a conventional implant inventory. These aren't trivial obstacles. But they operate against a backdrop of demand that is structurally growing: arthritis affects more than 58 million American adults, per the CDC, and that number tracks directly with an aging population that has no intention of accepting limited mobility as inevitable.

The longer arc here isn't about printers replacing surgeons or algorithms replacing clinical judgment. It's about manufacturing finally catching up to what anatomy actually requires — which is not a medium, and not a large, but something built for the specific person on the table. As robotic-assisted surgery systems increasingly pair with patient-specific implant designs, and as AI-driven preoperative planning software shortens the time between scan and sterile implant, the case for custom orthopedics will become harder and harder for even the most conservative surgical departments to dismiss.